Digital medicine products need to be developed along a strategic pathway that progressively builds a dossier of evidence. Clinical validation studies are often pivotal to garnering approval with regulatory bodies. Equally important is the need to build a broad dossier of evidence that supports both economic and clinical value propositions. Medullan works with digital medicine sponsors to help select study design and endpoints as well as contract with high impact partners organizations and healthcare systems. We navigate the logistical complexities of setting up virtual and hybrid studies for digital medicine validation and can run validation trials as a CRO.
December 20, 2019